Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis:

Multiple Sclerosis Journal – Experimental, Translational and Clinical

Bronwen Connor¹  Anne Camille La Flamme²  Nikki Templeton³  Pirooz Zareie³  Laura K Green⁴  Robert A Keyzers⁵ 

[1] Department of Pharmacology and Clinical Pharmacology, University of Auckland, New Zealand;Malaghan Institute for Medical Research, New Zealand;School of Biological Sciences and School of Chemical and Physical Sciences, Victoria University of Wellington, New Zealand;School of Biological Sciences, Victoria University of Wellington, New Zealand;School of Chemical and Physical Sciences, Victoria University of Wellington, New Zealand

关键词: Experimental autoimmune encephalomyelitis;    multiple sclerosis;    clozapine;    atypical antipsychotic agents;    glatiramer acetate;    immune modulation;   

DOI  :  10.1177/2055217317698724

学科分类：医学（综合）

来源: Sage Journals

【 授权许可】

CC BY-NC